Kevin Collins, MD
Orthopaedic Surgery · Columbus, GANPI 1487696225
Payments from drug & device makers
Across 18 payments — averaging $238.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Smith+Nephew$145
- Boston Scientific$104
- CGG Medical Inc$86
- Pacira Therapeutics, Inc.$64
- Bioventus LLC$33
- plus $108 from 6 others
What the payments were for
- Speaking & faculty fees$3,75087%
- Food & beverage$54013%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $3,750 |
| Smith+Nephew | 3 | $145 |
| Boston Scientific | 1 | $104 |
| CGG Medical Inc | 2 | $86 |
| Pacira Therapeutics, Inc. | 4 | $64 |
| Bioventus LLC | 1 | $33 |
| Next Science LLC | 1 | $28 |
| KCI USA, Inc. | 1 | $21 |
| Avanos Medical | 1 | $18 |
| Zimmer Biomet | 1 | $18 |
| Aroa Biosurgery Incorporated | 1 | $17 |
| Johnson & Johnson | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,290 in reported general payments places this provider in the 55th percentile of 654 orthopaedic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 98 | $1,119 |
| Celecoxib | 100 | $1,094 |
| Gabapentin | 60 | $794 |
| Diclofenac Sodium | 67 | $784 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 65 | $429 |
| Ibuprofen | 44 | $415 |
| Ondansetron Hcl | 41 | $265 |
| Naproxen | 15 | $200 |
| Cephalexin | 16 | $200 |
| Meloxicam | 72 | $196 |
| Methylprednisolone | 25 | $156 |
| Cyclobenzaprine Hcl | 11 | $112 |
| Cefadroxil | 14 | $110 |
| Tramadol Hcl | 37 | $98 |
| Hydromorphone Hcl | 14 | $49 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Columbus
- John DorchakColumbus$3.8M
- John BurkusColumbus$600K
- Tamara HuffColumbus$158K
- Charles DecookCumming$48.3M
- Ormonde MahoneyAthens$10.8M
- Daxes BanitWarner Robins$5.7M
- Daniel SilcoxAtlanta$3.4M
- Dennis DevitoAtlanta$1.5M
- George GuildCumming$1.4M
- Jon MinterAlpharetta$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.